Inventor · disambiguated record
James C. Barrow
Also filed as: BARROW JAMES · BARROW JAMES C · BARROW JAMES COLIN
47 granted patents·23 pending applications·148 citations·filing 1999–2024
97Inventor score
Top patents by PatentIndex Score
70 records- 0194US8263627B2Pyridyl amide T-type calcium channel antagonistsBARROW JAMES C·Filed 2011·Granted Sep 11, 2012·33 cites·11 claims
- 0291US7875636B2Pyridyl amide T-type calcium channel antagonistsMERCK SHARP & DOHME·Filed 2007·Granted Jan 25, 2011·18 cites·15 claims
- 0384US10844070B2Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous systemUNIV JOHNS HOPKINS·Filed 2020·Granted Nov 24, 2020·1 cites·28 claims
- 0484US10266534B2Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous systemUNIV JOHNS HOPKINS·Filed 2015·Granted Apr 23, 2019·3 cites·12 claims
- 0584US2023304050A1Enzymatic modification of oilDSM NUTRITIONAL PRODUCTS AG·Filed 2023·Application pending·0 cites
- 0682US9023616B2Oil producing microbes and method of modification thereofRADIANINGTYAS HELIA·Filed 2007·Granted May 5, 2015·11 cites·11 claims
- 0781US11136322B2Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous systemUNIV JOHNS HOPKINS·Filed 2019·Granted Oct 5, 2021·1 cites·22 claims
- 0880US6403612B2Thrombin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Jun 11, 2002·9 cites·5 claims
- 0979US7745452B2Quinazolinone T-type calcium channel antagonistsMERCK SHARP & DOHME·Filed 2006·Granted Jun 29, 2010·4 cites·12 claims
- 1077US9885068B2Enzymatic modification of oilDSM NUTRITIONAL PRODUCTS AG·Filed 2013·Granted Feb 6, 2018·1 cites·11 claims
- 1177US8637513B2Heterocycle phenyl amide T-type calcium channel antagonistsBARROW JAMES C·Filed 2008·Granted Jan 28, 2014·4 cites·12 claims
- 1277US6515011B2Thrombin inhibitorsMERCK & CO INC·Filed 2001·Granted Feb 4, 2003·11 cites·23 claims
- 1376US8530483B2Substituted azabenzoxazolesBARROW JAMES C·Filed 2009·Granted Sep 10, 2013·4 cites·13 claims
- 1475US6544982B1Thrombin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Apr 8, 2003·5 cites·7 claims
- 1574US8003653B2Imidazolidinone compounds useful as β-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK SHARP & DOHME·Filed 2006·Granted Aug 23, 2011·4 cites·19 claims
- 1673US6534510B2Thrombin inhibitorsMERCK & CO INC·Filed 2001·Granted Mar 18, 2003·8 cites·7 claims
- 1772US8389720B2Quinolone neuropeptide S receptor antagonistsBARROW JAMES C·Filed 2009·Granted Mar 5, 2013·1 cites·8 claims
- 1872US2025179076A1SUBSTITUTED BENZOPYRAZOLO[1,5-a][1,4]DIAZEPINES AS GABA POSITIVE ALLOSTERIC MODULATORSUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 1971US6515023B2Thrombin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Feb 4, 2003·6 cites·8 claims
- 2070US11649473B2Enzymatic modification of oilDSM NUTRITIONAL PRODUCTS AG·Filed 2019·Granted May 16, 2023·0 cites·16 claims
- 2170US10415065B2Enzymatic modification of oilDSM NUTRITIONAL PRODUCTS AG·Filed 2018·Granted Sep 17, 2019·0 cites·31 claims
- 2270US7144899B2Thrombin inhibitorsMERCK & CO INC·Filed 2002·Granted Dec 5, 2006·5 cites·9 claims
- 2370US6610701B2Thrombin inhibitorsMERCK & CO INC·Filed 2002·Granted Aug 26, 2003·5 cites·19 claims
- 2469US8501773B24-fluoro-piperidine T-type calcium channel antagonistsBARROW JAMES C·Filed 2006·Granted Aug 6, 2013·1 cites·10 claims
- 2568US6462050B1Thrombin inhibitorsMERCK & CO INC·Filed 2001·Granted Oct 8, 2002·4 cites·19 claims
- 2668US6387911B1Pyrazinone thrombin inhibitorsMERCK & CO INC·Filed 2000·Granted May 14, 2002·4 cites·14 claims
- 2766US12049467B2Substituted benzopyrazolo[1,5-a][1,4]diazepines as GABA positive allosteric modulatorsUNIV JOHNS HOPKINS·Filed 2022·Granted Jul 30, 2024·0 cites·25 claims
- 2865US9024032B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted May 5, 2015·1 cites·86 claims
- 2965US7550481B2Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Jun 23, 2009·2 cites·21 claims
- 3065US2021163490A1Peripherally restricted gaba positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous systemUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 3164US9309199B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted Apr 12, 2016·1 cites·16 claims
- 3261US2025042855A1Peripherally and luminally-restricted inhibitors of the serotonin transporter as treatments for disorders of gastrointestinal motility and gut-brain axisUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 3360US12234221B2Pyridine carboxamide compounds for inhibiting NAV1.8LIEBER INST INC·Filed 2019·Granted Feb 25, 2025·0 cites·12 claims
- 3460US2025346572A1Non-acid inhibitors of inositol hexakisphosphate kinase (ip6k) and methods of use thereofLIEBER INST INC·Filed 2023·Application pending·0 cites
- 3555US2021261542A1Compounds which inhibit rna polymerase, compositions including such compounds, and their useUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 3655US2021139479A1COMT Inhibiting Methods and CompositionsLIEBER INST INC·Filed 2021·Application pending·0 cites
- 3754US7084134B2Thrombin inhibitorsMERCK & CO INC·Filed 2003·Granted Aug 1, 2006·0 cites·9 claims
- 3851US2025197396A1Compounds for inhibiting inositol hexakisphosphate kinase (ip6k) and methods of use thereofLIEBER INST INC·Filed 2021·Application pending·0 cites
- 3951US2024336574A1Methyl-substituted pyridine and pyridazine compounds, derivatives thereof, and methods of their useLATIGO BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4050US2023265092A1Compounds which inhibit rna polymeraseUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 4150US2023265091A1Compounds which inhibit rna polymeraseUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 4250US2011076230A1Novel Substituted IndolesBARROW JAMES C·Filed 2009·Application pending·0 cites
- 4350US2023257390A1Compounds which inhibit rna polymerase and their useUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 4449US2010216816A1Pyrazinyl amide-t type calcium channel antagonistsBARROW JAMES C·Filed 2008·Application pending·0 cites
- 4549US2010210671A1Quinazolinone T-Type Calcium Channel AntagonistsBARROW JAMES C·Filed 2008·Application pending·0 cites
- 4649US2010249176A1Heterocycle amide t-type calcium channel antagonistsBARROW JAMES C·Filed 2008·Application pending·0 cites
- 4748US10479790B2COMT inhibiting methods and compositionsLIEBER INST FOR BRAIN DEVELOPMENT·Filed 2018·Granted Nov 19, 2019·0 cites·20 claims
- 4848US2011081297A1Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-OxadiazolesBARROW JAMES C·Filed 2009·Application pending·0 cites
- 4946US11001581B2Compounds which inhibit RNA polymerase, compositions including such compounds, and their useUNIV JOHNS HOPKINS·Filed 2015·Granted May 11, 2021·0 cites·11 claims
- 5046US2022356176A1Kv11.1-3.1 INHIBITING METHODS AND COMPOSITIONSUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James C. Barrow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →